3 false false false false false false false false false true false false false false false false No description of principal activity 2022-01-04 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 13825723 2022-01-04 2023-01-31 13825723 2023-01-31 13825723 bus:OrdinaryShareClass1 2022-01-04 2023-01-31 13825723 bus:OrdinaryShareClass2 2022-01-04 2023-01-31 13825723 bus:OrdinaryShareClass3 2022-01-04 2023-01-31 13825723 bus:Director1 2022-01-04 2023-01-31 13825723 core:WithinOneYear 2023-01-31 13825723 core:ShareCapital 2023-01-31 13825723 core:RetainedEarningsAccumulatedLosses 2023-01-31 13825723 bus:SmallEntities 2022-01-04 2023-01-31 13825723 bus:AuditExemptWithAccountantsReport 2022-01-04 2023-01-31 13825723 bus:FullAccounts 2022-01-04 2023-01-31 13825723 bus:SmallCompaniesRegimeForAccounts 2022-01-04 2023-01-31 13825723 bus:PrivateLimitedCompanyLtd 2022-01-04 2023-01-31 13825723 bus:OrdinaryShareClass1 2023-01-31 13825723 bus:OrdinaryShareClass2 2023-01-31 13825723 bus:OrdinaryShareClass3 2023-01-31 13825723 bus:AllOrdinaryShares 2023-01-31
COMPANY REGISTRATION NUMBER: 13825723
MEHWESH MEDI CARE LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 January 2023
MEHWESH MEDI CARE LTD
FINANCIAL STATEMENTS
PERIOD FROM 4 JANUARY 2022 TO 31 JANUARY 2023
Contents
Pages
Balance sheet 1
Notes to the financial statements 2 to 3
MEHWESH MEDI CARE LTD
BALANCE SHEET
31 January 2023
31 Jan 23
Note
£
Current assets
Debtors
4
8,550
Cash at bank and in hand
33,560
------------
42,110
Creditors: amounts falling due within one year
5
( 9,469)
------------
Net current assets
32,641
------------
Total assets less current liabilities
32,641
------------
Net assets
32,641
------------
Capital and reserves
Called up share capital
6
110
Profit and loss account
32,531
------------
Shareholders funds
32,641
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.
For the period ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 2 October 2023 , and are signed on behalf of the board by:
Dr M A Qureshi
Director
Company registration number: 13825723
MEHWESH MEDI CARE LTD
NOTES TO THE FINANCIAL STATEMENTS
PERIOD FROM 4 JANUARY 2022 TO 31 JANUARY 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 35 Westgate, Huddersfield, West Yorkshire, HD1 1PA.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Debtors
31 Jan 23
£
Trade debtors
7,660
Called up share capital not paid
10
Director loan account
880
------------
8,550
------------
5. Creditors: amounts falling due within one year
31 Jan 23
£
Accruals and deferred income
900
Corporation tax
8,569
------------
9,469
------------
6. Called up share capital
Issued, called up and fully paid
31 Jan 23
No.
£
Ordinary A shares of £ 1 each
100
100
Ordinary B shares of £ 1 each
5
5
Ordinary C shares of £ 1 each
5
5
------------
------------
110
110
------------
------------
During the period, 100 Ordinary A, 5 Ordinary B and 5 Ordinary C class shares were issued.
7. Related party transactions
The directors's loan account of £880 included in debtors is unsecured, repayable on demand and is currently interest free. The company is controlled by M A Qureshi.